Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Eight risk factors were identified: menopause, early menopause, heredity, lifestyle (smoking, excess consumption of alcohol, physical inactivity, vitamin-D deficiency due to lack of sunlight exposure), diet (calcium deficiency and "women who have dieted all their lives"), body weight (underweight or overweight), treatment with corticosteroids, and diseases such as diabetes, hyperthyroidism, and rheumatoid arthritis.

Source: Physicians’ views of osteoporosis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Qualitative study.

Qualitative study

Examines experiences or meanings using qualitative methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients’ and Practitioners’ Views

Source: Article title.

Women were purposively sampled to ensure this diversity according to age (21 participants between 50 and 69 and 16 aged 70 or over), symptoms (16 fractures, 7 hip fractures), and self-reported compliance (19 women declaring to be adherent) [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients’ and Practitioners’ Views

Qualitative study · PLoS ONE · 2016

Original publication title

Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients’ and Practitioners’ Views

Sophie Alami; Lucile Hervouet; Serge Poiraudeau; Karine Briot; Christian Roux

© 2016 Alami et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Women’s and physicians’ perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease. A better understanding of women’s and physicians’ views, practices, and concerns related to PMO can improve osteoporosis management.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Study patients’ and physicians’ views regarding postmenopausal osteoporosis (PMO) to identify impediments to good care.

Source: Objective

Abstract: What methods does the paper describe?

A qualitative study involving 18 physicians and 37 women (age 57 to 87) with PMO.

Source: Methods

Abstract: Results

All women interviewed considered PMO to be somewhat normal wear-and-tear associated with old age. The women identified a large number of "causes" for osteoporosis but finally viewed it as chance. They all described its progression as slow. Three representations of PMO severity were identified: some women tended to interpreted it as benign (21), others tended to dramatize it (11), and the rest were uncertain (5). These representations did not appear linked to age or fracture. Even the women who associated fracture and PMO were uncertain of the link between them.

Fractures were considered to be random events, independent of osteoporosis. Women received general life-style recommendations from their physicians positively, but did not connect them specifically to osteoporosis. Indeed, these recommendations, along with the fear of side effects, the absence of tangible results of treatments, the view of PMO as a natural process, and the representations of PMO severity are factors that may deter treatments and impact compliance. As for the physicians, they identified eight risk factors, recognizing menopause as central to PMO and recognized the link between risk of fracture and PMO.

However, some considered the impact of fractures to be limited in time, and viewed PMO as a "benign" disease. Seeing the progression of PMO as slow and inevitable reduced their urgency to diagnose and treat it as compared to other diseases. Some physicians acknowledged limited mastery of the existing therapeutic arsenal and unsuccessful handling of patient compliance.

Source: Results

Abstract: Conclusion

Women’s and physicians’ perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease. A better understanding of women’s and physicians’ views, practices, and concerns related to PMO can improve osteoporosis management.

Source: Conclusion
Authors’ abstract

Background

Only a minority of patients at high risk for osteoporotic fracture receive treatment.

Objective

Study patients’ and physicians’ views regarding postmenopausal osteoporosis (PMO) to identify impediments to good care.

Methods

A qualitative study involving 18 physicians and 37 women (age 57 to 87) with PMO.

Results

All women interviewed considered PMO to be somewhat normal wear-and-tear associated with old age. The women identified a large number of "causes" for osteoporosis but finally viewed it as chance. They all described its progression as slow. Three representations of PMO severity were identified: some women tended to interpreted it as benign (21), others tended to dramatize it (11), and the rest were uncertain (5). These representations did not appear linked to age or fracture. Even the women who associated fracture and PMO were uncertain of the link between them.

Fractures were considered to be random events, independent of osteoporosis. Women received general life-style recommendations from their physicians positively, but did not connect them specifically to osteoporosis. Indeed, these recommendations, along with the fear of side effects, the absence of tangible results of treatments, the view of PMO as a natural process, and the representations of PMO severity are factors that may deter treatments and impact compliance. As for the physicians, they identified eight risk factors, recognizing menopause as central to PMO and recognized the link between risk of fracture and PMO.

However, some considered the impact of fractures to be limited in time, and viewed PMO as a "benign" disease. Seeing the progression of PMO as slow and inevitable reduced their urgency to diagnose and treat it as compared to other diseases. Some physicians acknowledged limited mastery of the existing therapeutic arsenal and unsuccessful handling of patient compliance.

Conclusion

Women’s and physicians’ perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease. A better understanding of women’s and physicians’ views, practices, and concerns related to PMO can improve osteoporosis management.

Publication and source details

Original title: Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients’ and Practitioners’ Views

Sophie Alami; Lucile Hervouet; Serge Poiraudeau; Karine Briot; Christian Roux

PLoS ONE · 2016

Competing Interests: SA and LH performed paid consultancy work for Interlis and Association de Recherche Clinique en Rhumatologie as sociologists participating in the qualitative survey (study design, data collection and analysis, decision to publish, and preparation of the manuscript). Merck Sharp and Dohme Laboratory provided a grant to the Association de Recherche Clinique en Rhumatologie, which hired Interlis to provide sociological expertise. The authors adhere to PLOS ONE policies on sharing data and materials.

Conceived and designed the experiments: SA LH SP KB CR. Performed the experiments: SA LH. Analyzed the data: SA LH SP KB CR. Contributed reagents/materials/analysis tools: SA LH SP KB CR. Wrote the paper: SA LH SP KB CR.

* E-mail: alami.sophie@noos.fr
© 2016 Alami et al2016Alami et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Association de Recherche Clinique en RhumatologieMerck Sharp and Dohme LaboratoryThe study was funded by the Association de Recherche Clinique en Rhumatologie, (ARCR), 75006 Paris, France. The Association received a grant from Merck Sharp and Dohme Laboratory. ARCR hired Interlis (SA) to provide sociological expertise and conduct the qualitative survey. The funder (ARCR) provided support in the form of honoraries for authors (SA, LH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck Sharp and Dohme Laboratory had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Interlis has no financial conflict with the materials discussed in the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T20:03:45.497697+00:00

DOI: 10.1371/journal.pone.0158365 · PMC4927112